Shengtai Pharmaceutical Inc. Stock Analysis SGTI

Shengtai Pharmaceutical, Inc. engages in the research, development, production and sale of active pharmaceutical ingredients and medical supplements. The company is headquartered in Weifang, Shandong and currently employs 733 full-time employees. The firm's products include pharmaceutical-grade glucose or dextrose, used for medical purposes, as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The firm's glucose series include dextrose monohydrate (DMH), dextrose anhydrous, oral glucose dextrin and rough glucose for other processing purposes. Its starch series include pharmaceutical starch and edible corn starch. The firm's customers include healthcare institutions, food and beverage companies, pharmaceutical companies, medical supply exporters and medical supply. The firm also exports its products to approximately 70 different countries overseas, such as Japan, Singapore, Korea, Australia, Russia and India.